In 2020, the challenge has been how fast systems can be set up and how much throughput they can offer as a war-like mentality develops in global labs.
A small number of high-end automated systems are mostly limited to independent reference laboratories and centralized hospital laboratories. Since 2012, Sansure has been exploring the development of automated nucleic acid extraction instruments. In that year,Sansure had already launched a high-throughput, highly-precision and top-efficiency system which allows a complete workflow of sample preprocessing and nucleic acid extraction. In order to meet costumer’s diversified need, Sansure has developed a series of instruments fit to different laboratories and different scenarios.
. Molecular Diagnostics Markets in The COVID-19 Era. Published on: July 9, 2020